These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2590269)

  • 21. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
    Meyer FP; Banditt P
    Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
    Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
    Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence of allopurinol-containing tablet preparations.
    Barthel W; Hüller G; Haustein KO
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):148-52. PubMed ID: 10190763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic study of the relative bioavailability and bioequivalence after oral intensive or repeated short term treatment with two polyamino acid formulations.
    Matera M; Castana R; Insirello L; Leonardi G
    Int J Clin Pharmacol Res; 1993; 13(2):93-105. PubMed ID: 8354595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correcting endogenous concentrations of testosterone influences bioequivalence and shows the superiority of TDS(R)-testosterone versus Androgel(R).
    Chik Z; Johnston A; Tucker AT; Kirby K; Alam CA
    Int J Clin Pharmacol Ther; 2009 Apr; 47(4):262-8. PubMed ID: 19356392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability of doxycycline from dissolved doxycycline hydrochloride tablets--comparison to solid form hydrochloride tablets and dissolved monohydrate tablets.
    Saano V; Paronen P; Peura P
    Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):471-4. PubMed ID: 2272707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A model study of bioequivalence of dissolved nifedipine from soft gelatin capsules].
    Menke G; Kausch M; Rietbrock N
    Arzneimittelforschung; 1988 Feb; 38(2):300-4. PubMed ID: 3370080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation of Cmax and Cmax/AUC in investigations of bioequivalence.
    Endrenyi L; Yan W
    Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):184-9. PubMed ID: 8500920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers.
    Jovanović D; Kilibarda V; Cirić B; Vucinić S; Srnić D; Vehabović M; Potogija N
    Clin Ther; 2005 Oct; 27(10):1588-95. PubMed ID: 16330294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].
    von Nieciecki A; Fuchs WS; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 34. Absorption of doxycycline from a controlled release pellet formulation: the influence of food on bioavailability.
    Williams DB; O'Reilly WJ; Boehm G; Story MJ
    Biopharm Drug Dispos; 1990 Mar; 11(2):93-105. PubMed ID: 2328303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability and bioequivalence requirements in the European community.
    Rauws AG
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():519-32. PubMed ID: 1820933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should licking behavior be considered in the bioavailability evaluation of transdermal products?
    Toutain PL; Modric S; Bousquet-Mélou A; Sallovitz JM; Lanusse C
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():39-43. PubMed ID: 22413790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of doxycycline hydrochloride via drinking water to turkeys under laboratory and field conditions.
    Santos MD; Vermeersch H; Remon JP; Schelkens M; De Backer P; Ducatelle R; Haesebrouck F
    Poult Sci; 1997 Oct; 76(10):1342-8. PubMed ID: 9316108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview on bioavailability and bioequivalence.
    Kaplan SA
    Psychopharmacol Bull; 1976 Oct; 12(4):50-1. PubMed ID: 972989
    [No Abstract]   [Full Text] [Related]  

  • 39. [Doxycycline preparations].
    Strøm I
    Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1989. PubMed ID: 1509467
    [No Abstract]   [Full Text] [Related]  

  • 40. When are bioavailability studies required? A German proposal.
    Gleiter CH; Klotz U; Kuhlmann J; Blume H; Stanislaus F; Harder S; Paulus H; Poethko-Müller C; Holz-Slomczyk M
    J Clin Pharmacol; 1998 Oct; 38(10):904-11. PubMed ID: 9807970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.